University of Tartu   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Tartu Estonia (1632)

Organization Overview

First Clinical Trial
2006
NCT01248338
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cardiology Clinic of Tartu University Clinics | Leho Rips | Tallinn Children's Hospital | Tallinn Children's Hospital, Dep. Hematology oncology, Tervise 28, Tallinn 13419, Estonia. | Tartu University | Tartu University Hospital | Tartu University Hospital Heart Clinic | Tartu University Hospital; University of Tartu | University of Tartu | University of Tartu, Estonia | University of Tartu, Institute of Physiology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Dental Caries (Phase 3)

Depressive Disorder, Major (Phase 4)

Glaucoma (Phase 3)

Glaucoma, Angle-Closure (Phase 3)

Glaucoma, Neovascular (Phase 3)

Glaucoma, Open-Angle (Phase 3)

Hypertension (Phase 4)

Intra-Abdominal Hypertension (Phase 4)

Leukemia (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Migraine Disorders (Phase 2)

Neonatal Sepsis (Phase 2)

Prostatic Neoplasms (Phase 3)

Sepsis (Phase 3)

Sick Sinus Syndrome (Phase 4)

Toxemia (Phase 3)

Uveitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 22
  • # of Trial APIs: 34